Company intelligence / Profile preview

Athens Research & Technology

Athens, Georgia, United States

Ownership: Private
Employees: ~25
Development stage: Other

Overview

Athens Research & Technology supplies high-purity native human and animal proteins and polyclonal antisera for academic and industry research, diagnostics, immunoassay kits, cell culture, and proof-of-concept biotherapeutic studies. Their products have supported published studies in inflammation, autoimmune disease, cancer, and more, and they serve over 250 labs annually.[3][5][6][8]

Therapeutic areas: ImmunologyNeurologyOncologyCardiovascular
Modalities: ProteinPolyclonal antibodyRecombinant protein
Industry: Chemicals & Materials

Partnerships

Biomedical Engineering programs at Georgia Institute of Technology and University of Georgia (co-op and academic partnership)[4]Various diagnostic and pharmaceutical companies (reagents supplier)[5][6][8]

Beyond the preview

Go deeper on Athens Research & Technology.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Athens Research & Technology.

Explore the full profile